Home
Conditions
Adenocarcinoma of the Pancreas

Clinical trial condition

Adenocarcinoma of the Pancreas

Explore clinical trials studying Adenocarcinoma of the Pancreas. Study availability and eligibility vary by location and protocol.

43 public trials 7 recruiting studies

Refine in advanced search Browse all conditions

Adenocarcinoma of the Pancreas trial results

Completed

Selumetinib and Erlotinib Hydrochloride in Treating Patients With Locally Advanced or Metastatic Pancreatic Cancer

NCT01222689

Conditions: Adenocarcinoma of the Pancreas, Digestive System Diseases, Digestive System Neoplasms, +9 more
Locations: UCSF-Mount Zion San Francisco, California, United States

Ohio State University Medical Center Columbus, Ohio, United States

View Trial Details

Completed

Dose Escalation Trial of AZD1775 and Gemcitabine (+Radiation) for Unresectable Adenocarcinoma of the Pancreas

NCT02037230

Conditions: Adenocarcinoma of the Pancreas
Locations: University of Michigan Hospital Ann Arbor, Michigan, United States

View Trial Details

Completed

Saracatinib in Treating Patients With Previously Treated Metastatic Pancreatic Cancer

NCT00735917

Conditions: Adenocarcinoma of the Pancreas, Digestive System Diseases, Digestive System Neoplasms, +8 more
Locations: Mayo Clinic in Arizona Scottsdale, Arizona, United States

University of Colorado at Denver Aurora, Colorado, United States

Mayo Clinic in Florida Jacksonville, Florida, United States

Wayne State University/Karmanos Cancer Institute Detroit, Michigan, United States

View Trial Details

Completed

Eribulin Mesylate as Second-Line Therapy for Locally Advanced, Unresectable, or Metastatic Pancreatic Cancer Patients

NCT00383760

Conditions: Adenocarcinoma of the Pancreas, Digestive System Diseases, Digestive System Neoplasms, +11 more
Locations: University Health Network-Princess Margaret Hospital Toronto, Ontario, Canada

View Trial Details

Completed

Perioperative Therapy for Resectable Pancreatic Cancer

NCT00609336

Conditions: Adenocarcinoma of the Pancreas, Digestive System Diseases, Digestive System Neoplasms, +10 more
Locations: Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium Seattle, Washington, United States

View Trial Details

Completed

Gemcitabine, Bevacizumab and Erlotinib in Pancreatic Cancer

NCT00366457

Conditions: Adenocarcinoma of the Pancreas, Digestive System Diseases, Digestive System Neoplasms, +7 more
Locations: Massachusetts General Hospital Boston, Massachusetts, United States

Beth Israel Deaconess Medical Center Boston, Massachusetts, United States

Dana-Farber Cancer Institute Boston, Massachusetts, United States

View Trial Details

Completed

Phase I Study of Gemcitabine, Sorafenib and Radiotherapy in Patients With Unresectable Pancreatic Cancer

NCT00375310

Conditions: Adenocarcinoma of the Pancreas, Digestive System Diseases, Digestive System Neoplasms, +7 more
Locations: Indiana University Simon Cancer Center Indianapolis, Indiana, United States

View Trial Details

Completed

Dasatinib in Treating Patients With Metastatic Pancreatic Cancer

NCT00474812

Conditions: Adenocarcinoma of the Pancreas, Digestive System Diseases, Digestive System Neoplasms, +8 more
Locations: Case Western Reserve University Cleveland, Ohio, United States

View Trial Details

Completed

Gamma Secretase Inhibitor RO4929097 in Previously Treated Metastatic Pancreas Cancer

NCT01232829

Conditions: Adenocarcinoma of the Pancreas, Digestive System Diseases, Digestive System Neoplasms, +8 more
Locations: University of Colorado Cancer Center - Anschutz Cancer Pavilion Aurora, Colorado, United States

University of Colorado Denver, Colorado, United States

Johns Hopkins University/Sidney Kimmel Cancer Center Baltimore, Maryland, United States

View Trial Details

Completed

Gemcitabine Hydrochloride and Tanespimycin in Treating Patients With Stage IV Pancreatic Cancer

NCT00577889

Conditions: Adenocarcinoma of the Pancreas, Digestive System Diseases, Digestive System Neoplasms, +8 more
Locations: Mayo Clinic Rochester, Minnesota, United States

View Trial Details

Adenocarcinoma of the Pancreas

Adenocarcinoma of the Pancreas trial results

Related conditions